MARKET

FLGT

FLGT

Fulgent Genetics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.76
-0.94
-8.03%
Closed 16:00 03/31 EDT
OPEN
11.70
PREV CLOSE
11.70
HIGH
11.98
LOW
10.73
VOLUME
320.17K
TURNOVER
--
52 WEEK HIGH
20.60
52 WEEK LOW
4.712
MARKET CAP
232.04M
P/E (TTM)
-397.0480
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average FLGT stock price target is 14.25 with a high estimate of 16.50 and a low estimate of 12.00.

EPS

FLGT News

More
  • Edited Transcript of FLGT earnings conference call or presentation 10-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 5d ago
  • Medtronic's Patent Challenge, And Other News: The Good, Bad And Ugly Of Biopharma
  • Seeking Alpha - Article · 03/19 20:57
  • DOW, REGN among premarket gainers
  • Seeking Alpha - Article · 03/17 13:22
  • Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)
  • GlobeNewswire · 03/17 13:00

Industry

Advanced Medical Equipment & Technology
-1.24%
Healthcare Equipment & Supplies
-0.66%

Hot Stocks

Symbol
Price
%Change

About FLGT

Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.
More

Webull offers kinds of Fulgent Genetics Inc stock information, including NASDAQ:FLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLGT stock news, and many more online research tools to help you make informed decisions.